Compounds > 1,3-dipropyl-8-cyclopentylxanthine

1,3-dipropyl-8-cyclopentylxanthine and candesartan

1,3-dipropyl-8-cyclopentylxanthine has been researched along with candesartan in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Albino-Teixeira, A; Fasching, A; Morato, M; Palm, F; Patinha, D; Pinho, D	1

Other Studies

1 other study(ies) available for 1,3-dipropyl-8-cyclopentylxanthine and candesartan

Article	Year
Angiotensin II contributes to glomerular hyperfiltration in diabetic rats independently of adenosine type I receptors. American journal of physiology. Renal physiology, 2013, Mar-01, Volume: 304, Issue:5 Topics: Adenosine A1 Receptor Antagonists; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Benzimidazoles; Biphenyl Compounds; Blood Pressure; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Dose-Response Relationship, Drug; Glomerular Filtration Rate; Kidney; Male; Rats; Receptor, Adenosine A1; Renal Circulation; Tetrazoles; Vascular Resistance; Xanthines	2013

Article

Year

Angiotensin II contributes to glomerular hyperfiltration in diabetic rats independently of adenosine type I receptors.

American journal of physiology. Renal physiology, 2013, Mar-01, Volume: 304, Issue:5

Topics: Adenosine A1 Receptor Antagonists; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Benzimidazoles; Biphenyl Compounds; Blood Pressure; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Dose-Response Relationship, Drug; Glomerular Filtration Rate; Kidney; Male; Rats; Receptor, Adenosine A1; Renal Circulation; Tetrazoles; Vascular Resistance; Xanthines

2013